Analysis of Geographic Areas
Regeneron Pharmaceuticals Inc. operates in 2 regions: United States and Rest of world.
Area Asset Turnover
Regeneron Pharmaceuticals Inc., asset turnover by geographic area
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 1.85 | 2.00 | 2.30 | 4.51 | 2.32 |
| Rest of world | 0.60 | 0.42 | 0.09 | 0.00 | 0.00 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
| Rest of world | Rest of world area asset turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |
Area Asset Turnover: United States
Regeneron Pharmaceuticals Inc.; United States; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net product sales | 7,199,700) | 6,753,700) | 6,820,700) | 12,117,200) | 5,567,600) |
| Net property, plant, and equipment | 3,883,800) | 3,375,000) | 2,960,000) | 2,684,400) | 2,397,800) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 1.85 | 2.00 | 2.30 | 4.51 | 2.32 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Net product sales ÷ Net property, plant, and equipment
= 7,199,700 ÷ 3,883,800 = 1.85
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Area Asset Turnover: Rest of world
Regeneron Pharmaceuticals Inc.; Rest of world; area asset turnover calculation
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net product sales | 429,500) | 324,300) | 73,000) | —) | —) |
| Net property, plant, and equipment | 715,900) | 771,400) | 803,000) | 797,800) | 823,800) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 0.60 | 0.42 | 0.09 | 0.00 | 0.00 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Area asset turnover = Net product sales ÷ Net property, plant, and equipment
= 429,500 ÷ 715,900 = 0.60
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Rest of world | Rest of world area asset turnover ratio improved from 2022 to 2023 and from 2023 to 2024. |
Net product sales
Regeneron Pharmaceuticals Inc., net product sales by geographic area
US$ in thousands
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 7,199,700) | 6,753,700) | 6,820,700) | 12,117,200) | 5,567,600) |
| Rest of world | 429,500) | 324,300) | 73,000) | —) | —) |
| Total | 7,629,200) | 7,078,000) | 6,893,700) | 12,117,200) | 5,567,600) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
Net property, plant, and equipment
Regeneron Pharmaceuticals Inc., net property, plant, and equipment by geographic area
US$ in thousands
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| United States | 3,883,800) | 3,375,000) | 2,960,000) | 2,684,400) | 2,397,800) |
| Rest of world | 715,900) | 771,400) | 803,000) | 797,800) | 823,800) |
| Total | 4,599,700) | 4,146,400) | 3,763,000) | 3,482,200) | 3,221,600) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).